In last trading session, AnaptysBio Inc (NASDAQ:ANAB) saw 0.67 million shares changing hands with its beta currently measuring 0.01. Company’s recent per share price level of $18.59 trading at -$0.28 or -1.48% at ring of the bell on the day assigns it a market valuation of $565.67M. That closing price of ANAB’s stock is at a discount of -122.22% from its 52-week high price of $41.31 and is indicating a premium of 34.32% from its 52-week low price of $12.21.
For AnaptysBio Inc (ANAB), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.50. Splitting up the data highlights that, out of 6 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 3 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
AnaptysBio Inc (NASDAQ:ANAB) trade information
Upright in the red during last session for losing -1.48%, in the last five days ANAB remained trading in the red while hitting it’s week-highest on Tuesday, 02/18/25 when the stock touched $18.59 price level, adding 13.82% to its value on the day. AnaptysBio Inc’s shares saw a change of 40.41% in year-to-date performance and have moved -3.63% in past 5-day. AnaptysBio Inc (NASDAQ:ANAB) showed a performance of 14.89% in past 30-days.
Wall Street analysts have assigned a consensus price target of 40 to the stock, which implies a rise of 53.52% to its current value. Analysts have been projecting 19 as a low price target for the stock while placing it at a high target of 90. It follows that stock’s current price would drop -2.21% in reaching the projected high whereas dropping to the targeted low would mean a loss of -2.21% for stock’s current value.
AnaptysBio Inc (ANAB) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -19.45% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -0.08% while estimates for its earnings growth in next 5 years are of 6.04%.
AnaptysBio Inc (NASDAQ:ANAB)’s Major holders
ECOR1 CAPITAL, LLC is the top institutional holder at ANAB for having 7.52 million shares of worth $188.48 million. And as of 2024-06-30, it was holding 27.4931 of the company’s outstanding shares.
The second largest institutional holder is FMR LLC, which was holding about 2.87 million shares on 2024-06-30. The number of shares represents firm’s hold over 10.4936 of outstanding shares, having a total worth of $71.94 million.
On the other hand, Vanguard Total Stock Market Index Fund and Fidelity Small Cap Growth Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 733.95 shares of worth $13.64 million or 2.41% of the total outstanding shares. The later fund manager was in possession of 625.15 shares on Oct 31, 2024 , making its stake of worth around $11.62 million in the company or a holder of 2.05% of company’s stock.
